In the antimicrobial resistance (AMR) landscape, Nordic countries occupy a unique position. They have been at the forefront of research, policy-making, regulation, diagnostics, surveillance and social engagement regarding AMR. In parallel, this geographical region is relatively spared from the burden of AMR. This provides the Nordic countries with the opportunity for the exploration of long-term AMR containment strategies.
Biocides are used ubiquitously in our societies and can be valuable allies in reducing the spread of infectious diseases, thereby decreasing the need for antibiotics. However, not all applications of biocides are equally relevant, and they can contribute to the spread of antibiotic resistance through mechanisms such as cross-resistance, co-selection, cross-selection, induction of de novo mutations and induction of horizontal gene transfer of antibiotic resistance genes.
Nordic countries are important consumers of biocides and have their own specificities when it comes to biocide consumption. Therefore, it is particularly relevant for the Nordic countries to evaluate the effects of biocides on AMR in realistic settings and to develop potential mitigation strategies, which are the primary objectives of the NordCide consortium. This research will be crucial for informing public health policies and practices to curb the spread of AMR.
The NordCide consortium brings together AMR research experts from diverse disciplines, encompassing the full spectrum of the One Health perspective. Their goal is to build on the strong foundation of AMR research in the Nordic countries by enhancing collaboration among partners and stakeholders. This collaboration aims to launch new research projects that address critical knowledge gaps regarding the effects of biocides on AMR. By promoting the responsible use of biocides, NordCide seeks to reduce the spread of AMR, playing a crucial role in safeguarding human health and ensuring that antimicrobials remain effective for future generations.